A Clinical Study of BT02 for the Treatment of Patients With Advanced Malignant Melanoma

NCT07107178 · clinicaltrials.gov ↗

PHASE1

Phase

NOT_YET_RECRUITING

Status

58

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Melanoma
Advanced Solid Tumor

Interventions

DRUG: BT02

Sponsor

Biotroy Therapeutics

Collaborators

[object Object]